COMMUNIQUÉS West-GlobeNewswire

Palisade Bio to Participate in Upcoming Investor Conferences
03/09/2026
Denver, CO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with [...]
Philips advances women’s health ultrasound with new single-transducer solution
03/09/2026
September 3, 2026 FDA 510(k) cleared and CE marked, the eV14-2v combines exceptional image quality and broad clinical capabilities in one lightweight transducer, helping streamline exams, support diagnostic confidence, [...]
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Cosmos Health: A Company Transformed — 2026 Year-to-Date
03/09/2026
Record Revenue Across All Quarters Reported. Balance Sheet Deleveraged. Capital Structure Streamlined. Proprietary IP Filed in Four Global Markets. U.S. Market Entered. Global rollout of proprietary brands continues. [...]
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
03/09/2026
Everest Medicines to Lead Commercialization in Greater China, Bringing Novel Innovation to Estimated 3-6 Million Chinese Patients with PSVT Approval Triggers $2.0 Million Payment to Milestone Pharmaceuticals MONTREAL [...]
Senior Diet App Launches Personalized Nutrition and Movement App for Adults Over 50
03/09/2026
Senior Diet Turns a Short Quiz Into a High-Protein Meal Plan and Low-Impact Exercise Routine for Healthy Weight-Loss NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Senior Diet has launched a personalized wellness app [...]
BAART Programs Expands Buprenorphine Treatment Access at 11 Locations Across Six States
03/09/2026
Participating opioid treatment centers are adding office-based buprenorphine treatment alongside established methadone maintenance programs LEWISVILLE, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- BAART Programs today [...]
Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease
03/09/2026
Daily treatment with oral gildeuretinol met the primary endpoint and resulted in a statistically significant reduction in the growth rate of retinal atrophic lesions compared to untreated group. Gildeuretinol was well [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of [...]
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
03/09/2026
Feature Explores the Real Biology Behind Recombinant Spider Silk and the Scientific Case for Kraig Labs' Production Platform ANN ARBOR, Mich., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB [...]
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
03/09/2026
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the [...]
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
03/09/2026
MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
03/09/2026
Fireside chat scheduled for Wednesday, September 9, 2026, at 11:30am ET NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and [...]
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
03/09/2026
- Data support the ongoing development of four investigational therapies for DMD amenable to skipping of exons 53, 45, 44 or 55, all of which are advancing into IND-enabling studies - - All development candidates [...]
Trevi Therapeutics to Participate in Upcoming September Conferences
03/09/2026
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
03/09/2026
SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Crescent Biopharma to Present at September Investor Conferences
03/09/2026
WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
03/09/2026
MILLBRAE, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious [...]
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
03/09/2026
CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT. NEW YORK and TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” [...]

Pages